- Home
- LAB vs NPCE Comparison
LAB vs NPCE Comparison
Compare LAB & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LAB | NPCE |
|---|---|---|
| Founded | 1999 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 488.4M | 485.6M |
| IPO Year | 2008 | 2021 |
Fundamental Metrics
Financial Performance| Metric | LAB | NPCE |
|---|---|---|
| Price | $0.94 | $14.00 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | $1.35 | ★ $18.33 |
| AVG Volume (30 Days) | ★ 2.3M | 192.0K |
| Earning Date | 05-18-2026 | 05-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 44.68 | 29.03 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $101,937,000.00 | $99,986,000.00 |
| Revenue This Year | N/A | $0.93 |
| Revenue Next Year | $2.63 | $25.47 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 25.13 |
| 52 Week Low | $0.92 | $7.56 |
| 52 Week High | $1.72 | $18.97 |
Technical Indicators
Market Signals| Indicator | LAB | NPCE |
|---|---|---|
| Relative Strength Index (RSI) | 23.71 | 42.84 |
| Support Level | N/A | $14.02 |
| Resistance Level | $1.41 | $16.96 |
| Average True Range (ATR) | 0.07 | 0.80 |
| MACD | -0.01 | 0.04 |
| Stochastic Oscillator | 2.75 | 47.47 |
Price Performance
Historical ComparisonAbout LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.